Skip to main content
. 2015 Oct 16;21(3):10.18553/jmcp.2015.21.3.210. doi: 10.18553/jmcp.2015.21.3.210

TABLE 2.

Frequency and Percentage of Treatment Patterns for Natalizumab Initiators with at Least 2 Years of Follow-up Data (N = 2,407)

      Nonpersistent in Year Post Persistent in Year Post Total
Nonpersistent in Year Prior
      n 1,451 132 1,583
% 91.66 8.34 100.0
Persistent in Year Prior
      n 731 2,456 3,187
% 22.94 77.06 100.0
Total
      n 2,182 2,588 4,770
% 45.74 54.26 100.0

Note: n equals the number of year-to-year treatment patterns; % equals the percentage of total treatment patterns based on prior year.